z-logo
open-access-imgOpen Access
Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28
Author(s) -
Soyoung Won,
YoonKyoung Sung,
SooKyung Cho,
ChanBum Choi,
EunMi Koh,
SeongKyu Kim,
Jinseok Kim,
TaeHwan Kim,
HyounAh Kim,
Seong-Su Nah,
SoYoung Bang,
ChangHee Suh,
Seung Cheol Shim,
DaeHyun Yoo,
Bo Young Yoon,
SangHoon Lee,
Sung Won Lee,
ShinSeok Lee,
Yeon-Ah Lee,
Jaejoon Lee,
Jisoo Lee,
HyeSoon Lee,
Mi Kyoung Lim,
JaeBum Jun,
Chan Hong Jeon,
Young Ok Jung,
Won Tae Chung,
HoonSuk Cha,
JungYoon Choe,
SeungJae Hong,
SangCheol Bae
Publication year - 2014
Publication title -
journal of rheumatic diseases
Language(s) - English
Resource type - Journals
eISSN - 2093-940X
pISSN - 2233-4718
DOI - 10.4078/jrd.2014.21.2.64
Subject(s) - medicine , rheumatoid arthritis , reimbursement , infliximab , guideline , tnf inhibitor , physical therapy , etanercept , disease , pathology , health care , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom